A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences